Clinical Trials Directory

Trials / Unknown

UnknownNCT04782908

Hemodynamic Implications of Transcatheter Tricuspid Valve Repair in HFpEF Patients

Hemodynamic Characterisation of Patients Undergoing Transcatheter Tricuspid Valve Edge-to-edge Repair in Patients With Severe Tricuspid Regurgitation and Heart Failure With Preserved Ejection Fraction

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Heart Center Leipzig - University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to investigate the pathophysiological implications of transcatheter tricuspid valve edge-to-edge repair in patient with heart failure and preserved ejection fraction and severe tricuspid regurgitation. Changes in right- and left-ventricular function as well as the interventricular dependence will be analysed on a multimodal basis including pressure-volume loop analysis and cardiac magnetic resonance imaging.

Conditions

Interventions

TypeNameDescription
DEVICETranscatheter tricuspid valve edge-to-edge repairTranscatheter tricuspid valve edge-to-edge repair is an interventional approach to treat severe tricuspid regurgitation. Under general anesthesia a clip delivery system is forwarded through the vena femoralis and right atrium in the right ventricle. A clip is deployed to clamp the tricuspid valve and reduce tricuspid valve regurgitation.

Timeline

Start date
2021-03-01
Primary completion
2022-03-30
Completion
2022-06-30
First posted
2021-03-04
Last updated
2021-04-19

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04782908. Inclusion in this directory is not an endorsement.